Paper Review Records
全部论文审稿周期
15 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期;保留 PDF/DOI/网页源链接
77
天
Association of the IASLC histologic grading system with aggressive pathologic features in invasive non-mucinous lung adenocarcinoma
作者
Herui Han; Zirui Zhu; Jie Gao; Yiming Liu; Mingchuan Hu; Xiangming Qiu; Xizhe Zhang; Yuan Liu; Wenjin Pan; Xinran Tian; Xinyang Li; Zhiqiang Xue展开收起
作者单位
Medical School of Chinese PLA, Beijing 100853, China; Department of Thoracic Surgery, the First Medical Centre, Chinese PLA General Hospital, Beijing 100853, China; Department of Pathology, the First Medical Centre, Chinese PLA General Hospital, Beijing 100853, China; School of Medicine, Nankai University, Tianjin 300071, China展开收起
64
天
Integrated histopathological, immunohistochemical, and molecular profiling reveals hidden heterogeneity within histologic subtypes of thymoma
作者
Yi-Chen Yeh; Min-Shu Hsieh; Lei-Chi Wang; Ping-Yuan Chu; Yu-Chao Wang; Po-Kuei Hsu展开收起
作者单位
Department of Pathology and Laboratory Medicine, Taipei Veterans General Hospital, Taipei, Taiwan; School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan; Graduate Institute of Pathology, National Taiwan University College of Medicine, Taipei, Taiwan; Department of Pathology, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan; Institute of Biomedical Informatics, National Yang Ming Chiao Tung University, Taipei, Taiwan; Digital Medicine and Smart Healthcare Research Center, National Yang Ming Chiao Tung University, Taipei, Taiwan; Division of Thoracic Surgery, Department of Surgery, Taipei Veterans General Hospital, Taipei, Taiwan; Department of Surgery, School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan展开收起
74
天
From whole-exome sequencing to functional insight: Characterization of rare germline variants in lung cancer
作者
Simone Bonora; Maron Daw; Claudio Tabolacci; Alessio Cortellini; Fabrizio Citarella; Maria Luisa Scattoni; Loredaria Adamo; Anna Marabotti; Carla Lintas; Fiorella Gurrieri展开收起
作者单位
Department of Chemistry and Biology “A. Zambelli”, University of Salerno, Via Giovanni Paolo II, 132, Fisciano, SA, 84084, Italy; Medical Genetics Laboratory, Department of Medicine and Surgery, University Campus Bio-Medico of Rome, Via Alvaro del Portillo 21, Roma, 00128, Italy; Operative Research Unit of Medical Genetics, Fondazione Policlinico Universitario Campus Bio-Medico, Via Alvaro del Portillo 200, Roma, 00128, Italy; National Center for Rare Diseases, Istituto Superiore Di Sanità, Viale Regina Elena 299, Rome, 00161, Italy; Department of Medicine and Surgery, University Campus Bio-Medico of Rome, Via Alvaro del Portillo 21, Roma, 00128, Italy; Operative Research Unit of Medical Oncology, Fondazione Policlinico Universitario Campus Bio-Medico, Via Alvaro del Portillo 200, Roma, 00128, Italy; Department of Surgery and Cancer, Imperial College of London, Hammersmith Hospital Campus, Du Cane Road, London, UK展开收起
110
天
Real-world effectiveness and safety of lurbinectedin in previously treated small cell lung cancer: results from Jazz EMERGE 402
作者
Firas B. Badin; Philip E. Lammers; Geoffrey Liu; Leonid Shunyakov; Shaqil N. Kassam; Mehul P. Patel; Yan Ji; Catherine Labbé; Dennis Slater; Viral Rabara; Mehmood H. Hashmi; Shaker R. Dakhil; Matthias Weiss; John Migas; Alan C. Gowan; Nicole Bouchard; Paul Wheatley-Price; Samuel Nadeau; Badri Rengarajan; Raj Hanvesakul; Douglas S. Fuller; Balazs Halmos展开收起
作者单位
Baptist Health Medical Group, Lexington, KY, USA; Baptist Cancer Center, Memphis, TN, USA; Princess Margaret Cancer Centre, Toronto, ON, Canada; Carrie J. Babb Cancer Center, Bolivar, MO, USA; Southlake Regional Health Centre, Newmarket, ON, Canada; Rochester Regional Health, Rochester, NY, USA; HealthPartners Cancer Center at Regions Hospital, Saint Paul, MN, USA; Centre de Recherche de l’Institut Universitaire de Cardiologie et de Pneumologie de Québec, Université Laval, Québec City, QC, Canada; Eastern Connecticut Hematology and Oncology Associates, Norwich, CT, USA; Carolina Blood and Cancer Care Associates, Rock Hill, SC, USA; Stormont Vail Health, Topeka, KS, USA; Cancer Center of Kansas, Wichita, KS, USA; ThedaCare, Appleton, WI, USA; Mid-Illinois Hematology and Oncology Associates, Ltd., Normal, IL, USA; Baylor Scott & White Medical Center, Temple, TX, USA; Centre Hospitalier Universitaire de Sherbrooke, Université de Sherbrooke, Sherbrooke, QC, Canada; The Ottawa Hospital Cancer Centre, Ottawa, ON, Canada; Centre Intégré de Santé et de Services, Sociaux du Bas Saint-Laurent Hôpital, Rimouski, QC, Canada; Jazz Pharmaceuticals, Palo Alto, CA, USA; Jazz Pharmaceuticals, Oxford, England, UK; Jazz Pharmaceuticals, Philadelphia, PA, USA; Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY, USA展开收起
107
天
Multicenter case series of pulmonary sclerosing pneumocytoma coinciding with typical carcinoid: Shared AKT1 p.E17K mutation in mixed-growth lesions
作者
Weijie Chen; Yongtong Wang; Yue Wang; Runan Zhao; Zhengwei Dong; Yan Huang; Likun Hou; Chunyan Wu; Liye Zhang; Huikang Xie展开收起
作者单位
Department of Pathology, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China; School of Life Science and Technology, ShanghaiTech University, Shanghai 201210, China; Department of Pathology, Fudan University Shanghai Cancer Center, Shanghai, China; Department of Pathology, Changhai Hospital, Naval Military Medical University, Shanghai, China; Shanghai Clinical Research and Trial Center, Keyuan Road, Pudong New District, Shanghai 201210, China展开收起
169
天
Subtyping limited stage small cell lung cancer (LS SCLC) reveals inflammatory subtypes with improved chemoradiotherapy outcomes
作者
Rafael Oliveira; Tarje Halvorsen; Kristin Killingberg; Elisabeth Fritzke Emdal; Vibeke Grotnes Dale; Bjørn Henning Grønberg; Pål Sætrom展开收起
作者单位
Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology (NTNU), Trondheim, Norway; Department of Oncology, St. Olavs Hospital HF, Trondheim University Hospital, Trondheim, Norway; Department of Pathology, St. Olavs Hospital HF, Trondheim University Hospital, Trondheim, Norway; Department of Computer Science, Norwegian University of Science and Technology (NTNU), Trondheim, Norway; St. Olavs Hospital HF, Central Staff, Trondheim University Hospital, Trondheim, Norway展开收起
FAQ
LUNG CANCER审稿要多久?
截至2026-11-13,CrushSCI 收录了 LUNG CANCER 的 15 篇完整审稿记录。最快一篇从收稿到录用用了 54 天(Environmental asbestos exposure and lung cancer burden compared with mesothelioma in rural Türkiye: A 33-Year population-based cohort study,2026-07-01 收稿,2026-08-24 录用),最慢一篇用了 169 天;平均 88.3 天,中位数 84 天。
Expert Matching · Case Demo
把投稿要求,转成可验证的期刊方案
说清专业、时限和作者背景,CrushSCI 结合真实审稿样本,给出拟题方向、期刊初筛与周期判断。
